FDA Regulatory Bottlenecks Threaten Survival of SMEs

• Collins Sefa
• July 24, 2025
• 18

Bureaucratic bottlenecks and high regulatory costs at the Food and Drugs Authority (FDA) are crippling small- and medium-sized enterprises (SMEs), discouraging them from obtaining sanitary permits and product approvals—raising both public health concerns and questions